1. Home
  2. CMCM vs MIST Comparison

CMCM vs MIST Comparison

Compare CMCM & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheetah Mobile Inc. each representing fifty (50)

CMCM

Cheetah Mobile Inc. each representing fifty (50)

HOLD

Current Price

$7.38

Market Cap

188.7M

Sector

Technology

ML Signal

HOLD

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$1.69

Market Cap

176.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMCM
MIST
Founded
2009
2003
Country
China
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.7M
176.3M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
CMCM
MIST
Price
$7.38
$1.69
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
22.9K
1.2M
Earning Date
03-26-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.80
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.27
N/A
Revenue Next Year
$39.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.28
$0.63
52 Week High
$9.44
$3.06

Technical Indicators

Market Signals
Indicator
CMCM
MIST
Relative Strength Index (RSI) 53.15 45.90
Support Level $6.69 $1.60
Resistance Level $7.05 $1.79
Average True Range (ATR) 0.48 0.08
MACD 0.01 0.01
Stochastic Oscillator 49.03 61.54

Price Performance

Historical Comparison
CMCM
MIST

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: